drugset / Trial / NCT01763255

Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy

NCT01763255 ↗

Phase 1/2 Completed 8 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Cerebral palsy (CP) is condition, sometimes thought of as a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing, and thinking.Cerebral palsy is caused by injuries or abnormalities of the brain. Most of these problems occur as the baby grows in the womb, but they can happen at any time during the first 2 years of life, while the baby's brain is still developing.Bone marrow derived stem cells are known as a effective therapy. In this study the investigators evaluate the side effect of multiple intrathecal injection of bone marrow stem cell in patients with cerebral palsy.

Timeline

Start
2012-04
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CD133 cells Cell therapy — Intrathecal

Indications